Conditions: Obesity Type 2 Diabetes
Keywords: Obesity, Type 2 diabetes
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 2487
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the efficacy and safety of VI0521 compared to placebo in treatment of obesity in an adult population with obesity related co-morbid conditions.

Detailed description:

Arms:
arm 1: high dose experimental treatment arm 2: mid dose experimental treatment arm 3: Placebo

Interventions: intervention 1: VI-0521 intervention 2: VI-0521 intervention 3: VI-0521
Intervention descriptions: intervention 1: phentermine 15 mg and topiramate 92 mg, po once daily intervention 2: phentermine 7.5 mg and topiramate 46 mg, po once daily intervention 3: placebo

Protocol document: